Merck KGaA, Darmstadt, Germany, Licenses Four Oncology Research and Development Programs from Vertex and Becomes a Leader in DNA Damage and Repair
Download PDF Read more
Download PDF Read more
London – 11 January 2017 – Bringing ultrasound care into every setting in any environment around the globe1, GE Healthcare today unveiled its new generation of pocket-sized, dual-probe ultrasound, the Vscan Extend™2. From the hospital and ambulance to more rural environments1, Vscan Extend™ uses incredible image quality and wireless connectivity3 to help users increase clinical... Read more
2017 2017/01/11 Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of CAR gene therapy in Japan Kusatsu/Shiga, Japan — January 11, 2017 —Takara Bio Inc. (Takara Bio), today announced that it has submitted the Clinical Trial Notification for regenerative medicines to PMDA (Pharmaceuticals and Medical Devices Agency), Japanese regulatory... Read more
Maturity Date Extension and Full Cash Repayment by June 2022 BOTHELL, Wash., Jan. 10, 2017 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media (“BioLife”), today announced that it has reached an agreement to extend the maturity date and repayment schedule of its outstanding $4 million credit... Read more
Männedorf, Switzerland, January 10, 2017 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Dr. Klaus Lun, Head of Corporate Development and a member of the Management Board of the Tecan Group since June 2013, has been appointed Head of the Life Sciences Business division. On December 14, 2016, Tecan announced that Dr.... Read more
Download PDF Read more
Männedorf, Switzerland, January 10, 2017 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Dr. Klaus Lun, Head of Corporate Development and a member of the Management Board of the Tecan Group since June 2013, has been appointed Head of the Life Sciences Business division. On December 14, 2016, Tecan announced that Dr.... Read more
SAN DIEGO and HERCULES, Calif. — January 9, 2017 — Illumina, Inc. (NASDAQ: ILMN) and Bio‑Rad Laboratories, Inc. (NYSE: BIO)(NYSE: BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers... Read more
News Release FOR IMMEDIATE RELEASE January 9, 2017 For more information contact: Andy Cebulla Director of Investor Relations and Treasurer 952.937.4000 MTS ANNOUNCES THE APPOINTMENT OF MS. MAXIMILIANE STRAUB TO THE BOARD OF DIRECTORS Eden Prairie, Minn. – January 9, 2017 – MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems... Read more
Monday, January 9, 2017 MENLO PARK, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s ability to support important applications such as structural variant detection and targeted sequencing—including metagenomics, minor... Read more